Markets:

Overview

News

Currencies

International

Treasuries

BioNTech SE - American Depositary Shares (NQ:BNTX)

102.55 -1.33 (-1.28%)

Streaming Delayed Price Updated: 9:46 AM EST, Nov 14, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about BioNTech SE - American Depositary Shares

< Previous 1 2

...

12 13 14 15 16 17 18 19 20

...

70 71 Next >

BioNTech Prepares To Be Commercial Ready By 2025, Revenue Growth Expected To Return In 2025 ↗

January 09, 2024

On Tuesday, BioNTech SE (NASDAQ: BNTX) outlined priorities at the Annual J.P.

Via Benzinga

P/E Ratio Insights for BioNTech ↗

January 09, 2024

Via Benzinga

BioNTech Outlines 2024 Strategic Priorities at the 42nd Annual J.P. Morgan Healthcare Conference

January 09, 2024

From BioNTech SE

Via GlobeNewswire

Week In Review: 2024 Kicks Off With Three Deals Worth A Total Of $4 Billion ↗

January 07, 2024

Suzhou Ribo Life Science formed a collaboration with Boehringer Ingelheim in a deal that could be worth up to $2 billion. Additionally, Allorion Therapeutics has out-licensed global rights (ex-China)...

Via Talk Markets

Strides Toward Lower Drug Costs: Florida Becomes First To Receive Nod To Import Prescription Drugs from Canada ↗

January 05, 2024

The FDA has allowed Florida to import prescription drugs from Canada, potentially altering the landscape of how Americans access and afford their medications.

Via Benzinga

Comparative Study: BioNTech And Industry Competitors In Biotechnology Industry ↗

January 03, 2024

Via Benzinga

5 Value Stocks To Watch In The Healthcare Sector ↗

January 01, 2024

Via Benzinga

Pharmaceutical Giants Brace for Showdown as Medicare Drug Price Negotiations Are Poised For 2024 ↗

December 28, 2023

2024 will mark a pivotal moment for the healthcare industry, particularly in drug pricing negotiations.

Via Benzinga

How Is The Market Feeling About BioNTech? ↗

December 26, 2023

Via Benzinga

A Look Into Healthcare Sector Value Stocks ↗

December 25, 2023

Via Benzinga

BioNTech and DualityBio Receive FDA Breakthrough Therapy Designation for Antibody-Drug Conjugate Candidate BNT323/DB-1303 in Endometrial Cancer

December 21, 2023

From BioNTech SE

Via GlobeNewswire

Understanding BioNTech's Position In Biotechnology Industry Compared To Competitors ↗

December 20, 2023

Via Benzinga

COVAX Global Initiative For COVID-19 Vaccines Comes To An End Amid Shift To Regular Programs ↗

December 20, 2023

COVAX, the multilateral mechanism for equitable global access to COVID-19 vaccines launched in 2020, will close on 31 December 2023.&n

Via Benzinga

Why Is COVID-19 Vaccine Player CureVac Stock Plummeting Today? ↗

December 19, 2023

A German court has invalidated a patent central to CureVac N.V's (NASDAQ: CVAC) lawsuit against BioNTech SE (NASDAQ: BNTX) related to seeking fair compensation for infringement of a portfolio of

Via Benzinga

Topics Intellectual Property Lawsuit

BioNTech Achieves Milestone at mRNA-based Vaccine Manufacturing Site in Rwanda

December 18, 2023

From BioNTech SE

Via GlobeNewswire

What's Going On With BioNTech (BNTX) Shares? ↗

December 13, 2023

BioNTech SE - ADR (NASDAQ: BNTX) shares are trading lower by 5.6% to $93.10 Wednesday afternoon.

Via Benzinga

6 Analysts Have This to Say About BioNTech ↗

December 01, 2023

Via Benzinga

Analyst Ratings for BioNTech ↗

November 14, 2023

Via Benzinga

3 Stocks Down 30% or More This Year That Wall Street Expects to Skyrocket in 2024 ↗

December 18, 2023

Analysts think these beaten-down stocks could rebound strongly in the new year.

Via The Motley Fool

Pfizer Issues FY24 Forecast, Joins Target Hospitality, Southwest Airlines And Other Big Stocks Moving Lower On Wednesday ↗

December 13, 2023

U.S. stocks traded mostly higher, with the Nasdaq Composite gaining around 40 points on Wednesday. Shares of Pfizer Inc. (NYSE: PFE) shares fell sharply during Wednesday’s session after the company...

Via Benzinga

Topics Stocks

Pfizer Stock Tumble Steepens As Seagen Guidance Update Disappoints ↗

December 13, 2023

Pfizer's updated 2024 revenue figures, including Seagen, undercut the consensus target.

Via Investor's Business Daily

What's Going On With Moderna Stock Today? ↗

December 12, 2023

Moderna Inc (NASDAQ: MRNA) announced changes to its operating model to bring focus to its short- and

Via Benzinga

BioNTech to Inaugurate First African Site on December 18, 2023

December 12, 2023

From BioNTech SE

Via GlobeNewswire

BioNTech Stock Downgraded, Analyst Reflects Concerns Over Growth and Pipeline Development ↗

December 01, 2023

J.P.

Via Benzinga

Lululemon To Rally Around 16%? Here Are 10 Top Analyst Forecasts For Friday ↗

December 01, 2023

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.

Via Benzinga

Dell Reports Mixed Q3 Results, Joins Marvell Technology, Super Micro Computer And Other Big Stocks Moving Lower In Friday's Pre-Market Session ↗

December 01, 2023

U.S. stock futures traded higher this morning, with the Dow Jones futures gaining more than 80 points on Friday.

Via Benzinga

Topics Stocks

Why Is COVID-19 Vaccine Maker Moderna Stock Trading Lower Today? ↗

November 21, 2023

Moderna Inc (NASDAQ: MRNA) shares slipped on Tuesday trading after the European Patent Office said a contested mRNA patent owned by Moderna is invalid, marking a victory for Pfizer Inc (NYSE: PFE) /

Via Benzinga

Topics Intellectual Property

Acuitas Challenges CureVac in Legal Tussle Over COVID-19 Vaccine Technology ↗

November 15, 2023

Biotech company Acuitas Therapeutics has filed a lawsuit in Virginia federal court against Germany-based CureVac SE (NASDAQ: CVAC), accusing it of failing to credit Acuitas on patents related to...

Via Benzinga

Topics Intellectual Property Lawsuit

3 Biotech Stocks You’ll Regret Not Buying Soon: November 2023 ↗

November 14, 2023

The global biotechnology market could nearly triple by 2030. Investors should consider buying these biotech stocks before they explode.

Via InvestorPlace

Monday.Com To Rally Around 20%? Here Are 10 Top Analyst Forecasts For Tuesday ↗

November 14, 2023

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page

Via Benzinga

< Previous 1 2

...

12 13 14 15 16 17 18 19 20

...

70 71 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.